Cardiac resynchronization - A heart failure perspective

Annals of Noninvasive Electrocardiology

Volumn 10, Issue SUPPL. 4, 2005, Pages 16-23

  Rivera, Dee Ann ^a   Bristow, Michael R ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

CRT; Device therapy of heart failure; Heart failure therapy; ICD; Pharmacologic therapy of heart failure

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EPLERENONE; SPIRONOLACTONE; CARDIOTONIC AGENT;

CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVERSION; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; DEFIBRILLATOR; DEVICE; DRUG TOLERABILITY; HEART DISEASE; HEART FAILURE; HOSPITALIZATION; HUMAN; IMPLANTATION; MAJOR CLINICAL STUDY; MORTALITY; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; RISK REDUCTION; SUDDEN DEATH; TREATMENT OUTCOME; CLINICAL PRACTICE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; HEART PACING; METHODOLOGY; PRACTICE GUIDELINE; PROGNOSIS; REVIEW;

CARDIAC PACING, ARTIFICIAL; CARDIOTONIC AGENTS; CLINICAL TRIALS; ELECTRIC COUNTERSHOCK; HEART FAILURE, CONGESTIVE; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; PROGNOSIS; TREATMENT OUTCOME;

EID: 33644806876     PISSN: 1082720X     EISSN: 1542474X     Source Type: Journal    
DOI: 10.1111/j.1542-474X.2005.00076.x     Document Type: Conference Paper

References (32)

1. Ho KK, Pinsky JL, Kannel WB, et al. The epidemiology of heart failure: The Framingham Study. J Am Coll Cardiol 1993;22:6A-13A.
2. American Heart Association. 2005 Heart and Stroke Statistical Update. Dallas, TX: American Heart Association, 2005.
3. Haldeman GA, Croft JB, Giles WH, et al. Hospitalization of patients with heart failure: National Hospital Discharge Survey, 1985 to 1995. Am Heart J 1999;137:352-60.
4. Roger VL, Weston SA, Redfield MM, et al. Trends in heart failure incidence and survival in a community-based population. JAMA 2004;292:344-350.
5. Bristow MR. In Braunwald E, Zipes DP, Libby P (eds.) Management of Heart Failure. Heart Disease: A Textbook of CV Medicine, 7th edition. New York, NY: W.B. Saunders Company: Philadelphia, PA, 2004.
6. Bristow MR. Beta-adrenergic receptor blockade in chronic heart failure. Circulation 2000;101:558-569.
7. Lowes BD, Gilbert EM, Abraham WT, et al. Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents. N Engl J Med 2002;34:1357-1365.
8. Brown NJ, Vaughan DE. Angiotensin-converting enzyme inhibitors. Circulation 1998;97:1411-1420.
9. Sharon A. Hunt, David W. Baker, Marshall H. Chin, et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: Executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2001;38:2101-2113.
10. Pitt B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 1999;341:709-717.
11. Pitt B, Remme W, Zannad F, et al. Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 2003;348:1309-1321.
12. Mann DL, Bristow MR. Present and future treatment of heart failure. Circulation 2005;111:2837-2849.
13. Packer M. The impossible task of developing a new treatment for heart failure. J Cardiac Fail 2002;8:193-196.
14. Abraham WT, Fisher WG, Smith AL, et al. MIRACLE Study Group. Multicenter InSync Randomized Clinical Evaluation. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002;346:1845-1853.
15. Moss AJ, Zareba W, Hall WJ, et al. Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. New Engl J Med 2002;346:877-883.
16. Bristow MR, Saxon LA, Boehmer J, et al. Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiacresynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004;350:2140-2150.
17. Bardy GH, Lee KL, Mark DB, et al. Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. New Engl J Med 2005;352:225-237.
18. Cleland JG, Daubert JC, Erdmann E, et al. Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005;352:1539-1549.
19. Cardioverting device having a single intravascular catheter electrode system and method for its use. United States Patent 3,942,536 issued March 9, 1976. Inventors Mirowski M, Mower MM, Denniston RHIII; Assignee Mirowski Family Ventures, LLC.
20. Method and apparatus for treating hemodynamic dysfunction. United States Patent RE38,119 issued May 20, 2003. Inventor Mower MM; Assignee Mirowski Family Ventures, LLC.
21. Kass DA, Chen CH, Curry C, et al. Improved left ventricular mechanics from acute VDD pacing in patients with dilated cardiomyopathy and ventricular conduction delay. Circulation 1999;99:1567-1573.
22. Nelson GS, Berger RD, Fetics BJ, et al. Left ventricular or biventricular pacing improves cardiac function at diminished energy cost in patients with dilated cardiomyopathy and left bundle-branch block. Circulation 2000;102:3053-3059.
23. Auricchio A, Stellbrink C, Block M, et al. Effect of pacing chamber and atrioventricular delay on acute systolic function of paced patients with congestive heart failure. The Pacing Therapies for Congestive Heart Failure Study Group. The Guidant Congestive Heart Failure Research Group. Circulation 1999;99:2993-3001.
24. Aurricchio A, Stellbrink C, Sack S, et al. Long-term benefit as a result of pacing resynchronization in congestive heart failure: Results of the Path-CHF trial. Circulation 2000;102:II-693.
25. Baldasseroni S, Opasich C, Gorini M, et al. Italian Network on Congestive Heart Failure Investigators. Left bundle-branch block is associated with increased 1-year sudden and total mortality rate in 5517 outpatients with congestive heart failure: A report from the Italian network on congestive heart failure. Am Heart J 2002;143:398-405.
26. Xiao HB, Brecker S, Gibson DG. Effects of abnormal activation on the time course of left ventricular pressure in dilated cardiomyopathy. Br Heart J 1992;68:4033-4037.
27. Yu CM, Chau E, Sanderson JE, et al. Tissue Doppler echocardiographic evidence of reverse remodeling and improved synchronicity by simultaneously delaying regional contraction after biventricular pacing therapy in heart failure. Circulation 2002;105:438-445.
28. Wilkoff BL, Cook JR, Epstein AE, et al. Dual Chamber and VVI Implantable Defibrillator Trial Investigators. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. JAMA 2002;288:3115-3123.
29. Iuliano S, Fisher SG, Karasik PE, et al. QRS duration and mortality in patients with congestive heart failure. Am Heart J 2002;143:1085-1091.
30. Carson P, Bristow MR, Anand I, et al. Relation of cardiac device therapy to mode of death in advanced heart failure: The COMPANION Trial. J Am Coll Cardiol, December 2005.
31. Feldman AM, de Lissovoy G, Bristow MR, et al. Costeffectiveness of cardiac resynchronization therapy in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Trial. J Am Coll Cardiol, December 2005.
32. Bristow MR, Saxon LA, DeMarco T, et al. What does an ICD add to CRT in advanced heart failure patients? An analysis of major clinical endpoints in the CRT vs. CRT-D groups in the COMPANION trial (abstract). Circulation AHA 2005, October.